Clinical Trials Browser

Leukemia, Myeloid, Acute × lestaurtinib × Clear all

NCT00469859 2017-03-15

Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1/2 Completed

14 enrolled 9 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

NCT00079482 2016-07-21

Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute